61Cu-based Kalios radiodiagnostic (NUCLIDIUM)

N/A

Report date: 2025/11/14 17:20:09

NME

Base Information

Drug Name61Cu-based Kalios radiodiagnostic (NUCLIDIUM)

Drug Alias Name61Cu-based Kalios™ radiodiagnostic (NUCLIDIUM)61Cu-Kalios

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Copper > 61CuRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionPositron-emission tomography enhancers

TargetsUpdating

Therapy Area/IndicationsLung NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNuclidium AG

China Registration ClassN/A

Develop Information

Active CompaniesNuclidium AG

Inactive CompaniesN/A

Active IndicationsLung NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A